Report cover image

Global Coronary Stents Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 09, 2024
Length 160 Pages
SKU # EMAR18558262

Description

Global Coronary Stents Market Report and Forecast 2024-2032


Global Coronary Stents Market Report and Forecast 2024-2032

Global Coronary Stents Market Outlook

The global coronary stents market size was valued at USD 9.8 billion in 2023, driven by continuous innovation in the domain across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 16 billion by 2032.

Coronary Stents: Introduction

Coronary stents are tiny, expandable tubes used to treat narrowed or blocked coronary arteries, the vessels that supply blood to the heart. Often made of metal mesh, they're inserted into the artery via a catheter during a procedure known as angioplasty. Once in place, the stent expands against the artery walls, holding the artery open and improving blood flow. This helps alleviate symptoms like chest pain and reduces the risk of heart attacks.

Key Trends in the Global Coronary Stents Market

Continuous innovation has led to the development of more sophisticated stents, such as bioresorbable vascular scaffolds and drug-eluting stents with improved polymers and drugs, aimed at reducing the risk of artery re-narrowing and promoting better patient outcomes.

Increasing incidences of lifestyle-related health conditions, such as diabetes, obesity, and hypertension, are leading to a higher prevalence of coronary artery diseases globally, driving the demand for coronary stents.

There's a growing preference for minimally invasive surgeries over open surgeries, as they offer benefits like shorter recovery times and reduced post-operative complications, influencing the adoption rate of stenting procedures.

The market is also closely regulated, with frequent product approvals, recalls, and safety monitoring, ensuring the safety and efficacy of stents used in procedures.

Developing countries are experiencing rapid growth in the coronary stents market due to improving healthcare infrastructures, increasing access to medical care, and growing awareness about coronary artery disease treatments.

There is a trend towards customization and personalization of stents, including efforts to match stent types and materials to individual patient needs and anatomies for better outcomes.

Global Coronary Stents Market Segmentation

Market Breakup by Type
  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioresorbable Vascular Scaffold
Market Breakup by End User
  • Hospitals
  • Eye Clinics
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Coronary Stents Market Overview

North America leads in the coronary stents market due to advanced healthcare infrastructure, a high prevalence of coronary artery diseases, and strong adoption of advanced medical technologies. The region sees continuous innovation and significant investments in research and development, contributing to the growth and introduction of newer, more sophisticated stent technologies.

Europe follows closely, with a well-established healthcare system and increasing demand for minimally invasive procedures. The region's market is driven by the aging population, high healthcare expenditure, and favorable reimbursement policies. European countries are also notable for their stringent regulatory standards, ensuring high-quality and safe medical devices.

The Asia-Pacific region is witnessing rapid growth in the coronary stents market, fueled by increasing healthcare awareness, rising incidence of cardiovascular diseases, and improving healthcare infrastructure. Countries like China and India are pivotal due to their large populations and growing middle-class, which demands better healthcare services. The market is also benefiting from government initiatives aimed at modernizing healthcare and making advanced treatments more accessible.

Global Coronary Stents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abbott
  • Medtronic Plc
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • C. R. Bard, Inc.
  • Metabiomics
  • MicroPort Scientific Corporation
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

160 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Coronary Stents Market Overview
3.1 Global Coronary Stents Market Historical Value (2017-2023)
3.2 Global Coronary Stents Market Forecast Value (2024-2032)
4 Global Coronary Stents Market Landscape
4.1 Global Coronary Stents: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Coronary Stents: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Coronary Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Coronary Stents Market Segmentation
6.1 Global Coronary Stents Market by Type
6.1.1 Market Overview
6.1.2 Bare Metal Stents
6.1.3 Drug Eluting Stents
6.1.4 Bioresorbable Vascular Scaffold
6.2 Global Coronary Stents Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Eye Clinics
6.3 Global Coronary Stents Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Coronary Stents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Coronary Stents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Coronary Stents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Coronary Stents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Coronary Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Abbott
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Medtronic Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Boston Scientific Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Terumo Corporation
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 B Braun Melsungen AG
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Biotronik
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Stentys SA
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 C. R. Bard, Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Metabiomics
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 MicroPort Scientific Corporation
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us